Health & Personal Care
HIGH
FDA DRUG
Lannett Lisdexamfetamine Recall Alerts 40 mg Capsules for Label Mix-Up (2025)
Lannett Company, Inc. recalls 8,544 bottles of Lisdexamfetamine Dimesylate 40 mg capsules distributed nationwide. A labeling mix-up may have placed 30 mg and 40 mg strengths in mislabeled bottles. Healthcare providers and patients should stop use and contact the company for guidance.
Lisdexamfetamine Dimesylate
Labeling: Label